1-20 of 33
Nikhil C. Munshi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2288.
https://doi.org/10.1158/1078-0432.CCR-24-1089
Published: 15 May 2024
View article titled, Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Journal Articles

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam, Amit Agarwal, Melissa Anderson, Hervé Avet-Loiseau, Mark Bustoros, Jessica Chapman, Dana E. Connors, Ajeeta Dash, Alessandra Di Bacco, Ling Du, Thierry Facon, Juan Flores-Montero, Francesca Gay, Irene M. Ghobrial, Nicole J. Gormley, Ira Gupta, Howard Higley, Jens Hillengass, Bindu Kanapuru, Dickran Kazandjian, Gary J. Kelloff, Ilan R. Kirsch, Brandon Kremer, Ola Landgren, Elizabeth Lightbody, Oliver C. Lomas, Sagar Lonial, María-Victoria Mateos, Rocio Montes de Oca, Lata Mukundan, Nikhil C. Munshi, Elizabeth K. O'Donnell, Alberto Orfao, Bruno Paiva, Reshma Patel, Trevor J. Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A. Ross, Caroline C. Sigman, Katie L. Thoren, Suzanne Trudel, Gary Ulaner, Nancy Valente, Brendan M. Weiss, Elena Zamagni, Shaji K. Kumar
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5195–5212.
https://doi.org/10.1158/1078-0432.CCR-21-1059
Published: 01 October 2021
View article titled, Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Open the PDF for Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration in another window
Journal Articles

Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia

Na Li, Michael A. Lopez, Maria Linares, Subodh Kumar, Stefania Oliva, Joaquin Martinez-Lopez, Lian Xu, Yan Xu, Tommaso Perini, William Senapedis, Erkan Baloglu, Masood A. Shammas, Zachary Hunter, Kenneth C. Anderson, Steven P. Treon, Nikhil C. Munshi, Mariateresa Fulciniti
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 369–377.
https://doi.org/10.1158/1078-0432.CCR-18-1776
Published: 03 January 2019
View article titled, Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia
Open the PDF for Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma

Morihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, Mehmet K. Samur, Yu-Tzu Tai, Nikhil C. Munshi, Masahiro Kizaki, Teru Hideshima, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5225–5237.
https://doi.org/10.1158/1078-0432.CCR-17-0263
Published: 31 August 2017
View article titled, Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma
Open the PDF for Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells

Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Kemal Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4280–4289.
https://doi.org/10.1158/1078-0432.CCR-16-2692
Published: 01 August 2017
View article titled, Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells
Open the PDF for Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells in another window
Includes: Supplementary data
Journal Articles

Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma

Xiaoyan Feng, Li Zhang, Chirag Acharya, Gang An, Kenneth Wen, Lugui Qiu, Nikhil C. Munshi, Yu-Tzu Tai, Kenneth C. Anderson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4290–4300.
https://doi.org/10.1158/1078-0432.CCR-16-3192
Published: 01 August 2017
View article titled, Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
Open the PDF for Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet-Loiseau, Ann T. Farrell, Nicole J. Gormley, Shaji K. Kumar, Ola Landgren, Nikhil C. Munshi, Michele Cavo, Faith E. Davies, Alessandra Di Bacco, Jennifer S. Dickey, Steven I. Gutman, Howard R. Higley, Mohamad A. Hussein, J. Milburn Jessup, Ilan R. Kirsch, Richard F. Little, Robert D. Loberg, Jens G. Lohr, Lata Mukundan, James L. Omel, Trevor J. Pugh, Gregory H. Reaman, Michael D. Robbins, A. Kate Sasser, Nancy Valente, Elena Zamagni
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 3980–3993.
https://doi.org/10.1158/1078-0432.CCR-16-2895
Published: 01 August 2017
View article titled, The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Open the PDF for The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiles in Myeloma: Ready for the Real World?

Raphael Szalat, Herve Avet-Loiseau, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (22): 5434–5442.
https://doi.org/10.1158/1078-0432.CCR-16-0867
Published: 14 November 2016
View article titled, Gene Expression Profiles in Myeloma: Ready for the Real World?
Open the PDF for Gene Expression Profiles in Myeloma: Ready for the Real World? in another window
Journal Articles

A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma

Florence Magrangeas, Rowan Kuiper, Hervé Avet-Loiseau, Wilfried Gouraud, Catherine Guérin-Charbonnel, Ludovic Ferrer, Alexandre Aussem, Haytham Elghazel, Jérôme Suhard, Henri Der Sakissian, Michel Attal, Nikhil C. Munshi, Pieter Sonneveld, Charles Dumontet, Philippe Moreau, Mark van Duin, Loïc Campion, Stéphane Minvielle
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (17): 4350–4355.
https://doi.org/10.1158/1078-0432.CCR-15-3163
Published: 31 August 2016
View article titled, A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
Open the PDF for A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients

S. Peter Wu, Ruth M. Pfeiffer, Inhye E. Ahn, Sham Mailankody, Pieter Sonneveld, Mark van Duin, Nikhil C. Munshi, Brian A. Walker, Gareth Morgan, Ola Landgren
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4039–4044.
https://doi.org/10.1158/1078-0432.CCR-15-2366
Published: 14 August 2016
View article titled, Impact of Genes Highly Correlated with <em>MMSET</em> Myeloma on the Survival of Non-<em>MMSET</em> Myeloma Patients
Open the PDF for Impact of Genes Highly Correlated with <em>MMSET</em> Myeloma on the Survival of Non-<em>MMSET</em> Myeloma Patients in another window
Includes: Supplementary data
Journal Articles

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (5): 1222–1233.
https://doi.org/10.1158/1078-0432.CCR-15-0489
Published: 29 February 2016
View article titled, A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Includes: Supplementary data
Journal Articles

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Güllü Görgün, Mehmet K. Samur, Kristen B. Cowens, Steven Paula, Giada Bianchi, Julie E. Anderson, Randie E. White, Ahaana Singh, Hiroto Ohguchi, Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Teru Hideshima, Yu-Tzu Tai, Jacob P. Laubach, Noopur Raje, Florence Magrangeas, Stephane Minvielle, Herve Avet-Loiseau, Nikhil C. Munshi, David M. Dorfman, Paul G. Richardson, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4607–4618.
https://doi.org/10.1158/1078-0432.CCR-15-0200
Published: 14 October 2015
View article titled, Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Open the PDF for Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma

Don M. Benson, Jr, Adam D. Cohen, Sundar Jagannath, Nikhil C. Munshi, Gary Spitzer, Craig C. Hofmeister, Yvonne A. Efebera, Pascale Andre, Robert Zerbib, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4055–4061.
https://doi.org/10.1158/1078-0432.CCR-15-0304
Published: 14 September 2015
View article titled, A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma in another window
Journal Articles

Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy

Chirayu G. Patel, Andrew J. Yee, Tyler A. Scullen, Neeharika Nemani, Loredana Santo, Paul G. Richardson, Jacob P. Laubach, Irene M. Ghobrial, Robert L. Schlossman, Nikhil C. Munshi, Kenneth C. Anderson, Noopur S. Raje
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (15): 3955–3961.
https://doi.org/10.1158/1078-0432.CCR-14-0434
Published: 31 July 2014
View article titled, Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy
Open the PDF for Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy in another window
Journal Articles

Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, Lynne Uhl, Nikhil C. Munshi, Tami Katz, Bimalangshu R. Dey, Poorvi Somaiya, Heidi Mills, Federico Campigotto, Edie Weller, Robin Joyce, James D. Levine, Dimitrios Tzachanis, Paul Richardson, Jacob Laubach, Noopur Raje, Vassiliki Boussiotis, Yan Emily Yuan, Lina Bisharat, Viki Held, Jacob Rowe, Kenneth Anderson, Donald Kufe, David Avigan
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3640–3648.
https://doi.org/10.1158/1078-0432.CCR-13-0282
Published: 30 June 2013
View article titled, Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
Open the PDF for Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients in another window
Includes: Supplementary data
Journal Articles

New Strategies in the Treatment of Multiple Myeloma

Nikhil C. Munshi, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3337–3344.
https://doi.org/10.1158/1078-0432.CCR-12-1881
Published: 30 June 2013
View article titled, New Strategies in the Treatment of Multiple Myeloma
Open the PDF for New Strategies in the Treatment of Multiple Myeloma in another window
Journal Articles

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

Emanuela Leone, Eugenio Morelli, Maria T. Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2096–2106.
https://doi.org/10.1158/1078-0432.CCR-12-3325
Published: 15 April 2013
View article titled, Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth
Open the PDF for Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth in another window
Includes: Supplementary data
Journal Articles

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

Maria T. Di Martino, Emanuela Leone, Nicola Amodio, Umberto Foresta, Marta Lionetti, Maria R. Pitari, Maria E. Gallo Cantafio, Annamaria Gullà, Francesco Conforti, Eugenio Morelli, Vera Tomaino, Marco Rossi, Massimo Negrini, Manlio Ferrarini, Michele Caraglia, Masood A. Shammas, Nikhil C. Munshi, Kenneth C. Anderson, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6260–6270.
https://doi.org/10.1158/1078-0432.CCR-12-1708
Published: 14 November 2012
View article titled, Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence
Open the PDF for Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence in another window
Includes: Supplementary data
Journal Articles

Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders

Jooeun Bae, Robert Smith, John Daley, Naoya Mimura, Yu-Tzu Tai, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (17): 4850–4860.
https://doi.org/10.1158/1078-0432.CCR-11-2776
Published: 30 August 2012
View article titled, Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
Open the PDF for Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders in another window
Journal Articles

Significant Biological Role of Sp1 Transactivation in Multiple Myeloma

Mariateresa Fulciniti, Samir Amin, Puru Nanjappa, Scott Rodig, Rao Prabhala, Cheng Li, Stephane Minvielle, Yu-tzu Tai, Pierfrancesco Tassone, Herve Avet-Loiseau, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6500–6509.
https://doi.org/10.1158/1078-0432.CCR-11-1036
Published: 14 October 2011
View article titled, Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
Open the PDF for Significant Biological Role of Sp1 Transactivation in Multiple Myeloma in another window
Includes: Supplementary data